Synopsis of recent research by authors named "Richard M Zur"
- Richard M Zur's research predominantly focuses on the cost-effectiveness and clinical implications of various medical treatments and diagnostic strategies, highlighting the economic considerations in healthcare decision-making.
- His recent study on the cost-effectiveness of axicabtagene ciloleucel versus mosunetuzumab for treating relapsed or refractory follicular lymphoma emphasizes the importance of evaluating treatment costs from a payer perspective in the US healthcare system.
- Zur has also contributed to the understanding of genetic testing in autism spectrum disorder and pharmacogenomics, as well as public health interventions such as alcohol screening, showcasing a diverse range of studies aimed at improving clinical outcomes while ensuring economic viability.